key: cord-0281086-yr2v1pg9 authors: Deinhardt-Emmer, Stefanie; Böttcher, Sarah; Häring, Clio; Giebeler, Liane; Henke, Andreas; Zell, Roland; Hornung, Franziska; Brandt, Christian; Marquet, Mike; Mosig, Alexander S.; Pletz, Mathias W.; Schacke, Michael; Rödel, Jürgen; Heller, Regine; Nietzsche, Sandor; Löffler, Bettina; Ehrhardt, Christina title: SARS-CoV-2 causes severe alveolar inflammation and barrier dysfunction date: 2020-09-01 journal: bioRxiv DOI: 10.1101/2020.08.31.276725 sha: 6d4372735ab5aac8218240ebc426a944d6447fce doc_id: 281086 cord_uid: yr2v1pg9 Infections with SARS-CoV-2 lead to mild to severe coronavirus disease-19 (COVID-19) with systemic symptoms. Although the viral infection originates in the respiratory system, it is unclear how the virus can overcome the alveolar barrier, which is observed in severe COVID-19 disease courses. To elucidate the viral effects on the barrier integrity and immune reactions, we used mono-cell culture systems and a complex human alveolus-on-a-chip model composed of epithelial, endothelial, and mononuclear cells. Our data show that SARS-CoV-2 efficiently infected epithelial cells with high viral loads and inflammatory response, including the interferon expression. By contrast, the adjacent endothelial layer was no infected and did neither show productive virus replication or interferon release. With prolonged infection, both cell types are damaged, and the barrier function is deteriorated, allowing the viral particles to overbear. In our study, we demonstrate that although SARS-CoV-2 is dependent on the epithelium for efficient replication, the neighboring endothelial cells are affected, e.g., by the epithelial cytokine release, which results in the damage of the alveolar barrier function and viral dissemination. The novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) is a highly 67 pathogenic virus causing severe respiratory infections, described as coronavirus proinflammatory cytokines and thromboembolic events in various organs (Becker, 83 2020) . Consequently, SARS-CoV-2 is regarded as a pneumotropic virus that infects the 84 patient via the lung but can also cause a systemic infection that affects different organs 85 with a high mortality rate. 86 Little is known about the initial infection process in the alveolar lung tissue, 87 particularly about mechanisms that destroy the lung and mechanisms that allow the 88 virus to affect different organs in the body. Infection models that closely reflect the 89 patient's situation are mainly lacking in part due to the challenges to infect mice and 90 the difficulty of accessing and analyzing infected human alveolar lung cells. Up to 91 now, SARS-CoV-2 infection models have been mainly performed with human airway 92 (non-alveolar) cells or non-human cell lines that naturally express the ACE2 viral 93 receptor, such as the African Green Monkey Vero 76 cell line (Hoffmann et al., 2020) . 94 These cells lack organ-and species-specific characteristics of human lung epithelial 95 cells. For this purpose, cancerous lung epithelial cells (Calu-3 cells), can at least to some 96 extent, reflect the response of the lung epithelium to viral infection (Bestle et al., 2020) . 97 In our study, we present a human-specific in vitro, alveolus-on-a-chip model 98 but also for an adequate immune response. 106 We were able to show that SARS-CoV-2 replicates in the epithelial layer while 107 inducing an acute and robust inflammatory response followed by the destruction of 108 the epithelial layer. Interestingly, in this infection scenario, the endothelial cells were 109 not invaded by SARS-CoV-2 and did not propagate the virus, but nevertheless the 110 epithelial/endothelial barrier integrity was disrupted. 111 Efficient SARS-CoV-2 isolation from patients and propagation in cell-culture 115 To gain fully infectious viral particles for our studies, we collected three respiratory 116 specimens from qRT-PCR-proven COVID-19 patients and performed SARS-CoV-2 117 propagation in cell culture systems (Vero-76 cells). By repeated infection of host cells 118 and viral replication, we were able to isolate high viral titers originating from three 119 different patients. Within our studies, the SARS-CoV-2 isolates SARS-CoV-120 2/hu/Germany/Jena-vi005159/2020 (5159), SARS-CoV-2/hu/Germany/Jena-121 vi005187/2020 (5587) and SARS-CoV-2/hu/Germany/Jena-vi005588/2020 (5588) were 122 employed. Sequencing of virus isolates verified that all three viral strains belong to 123 SARS-CoV-2 (species Severe acute respiratory syndrome-related coronavirus, genus 124 Betacoronavirus) (Gorbalenya et al., 2020) . Phylogenetic analysis revealed a close 125 relationship of SARS-CoV-2 to the SARS-related coronaviruses RaTG13, bat-SL-126 CoVZXC21 and bat-SL-CoVZC45 ( Figure 1A ). Within the SARS-CoV-2 clade, the 127 sequences of strains 5587 and 5588 exhibit two base substitutions T8,782C (nsp1ab: released. These results indicate that SARS-CoV-2 induces replication complexes at ER-153 derived membranes, which were already shown for other types of coronaviruses 154 (Stertz et al., 2007) and also confirm the findings for Vero E6 cells (Ogando et al., 2020) . 155 To better mimic the situation in the human pulmonary alveoli, we performed the 156 infection in Calu-3 cells. In Figure 2B , immunofluorescence measurements compare 157 To further analyze the barrier integrity of the biochip system on a functional level, we 277 performed permeability assays using FITC-dextran to investigate the endothelial and 278 epithelial cell barrier integrity. We were able to show that SARS-CoV-2 significantly 279 increased the tissue permeability with its barrier function severely impaired (Figure 280 Many studies reveal that most severe cases of SARS-CoV-2 infections are not only due 307 to enhanced viral burden, but to a large extent due to aberrant immune responses 308 (Broggi et al., 2020) . 309 In our manuscript, we present an infection model that could be further used to study Netherlands) was used. RNA was thawed on ice. 400 nanogram (ng) RNA were 499 diluted in RNase free water to a volume of 13 μl. 2 μl gDNA removal mix were added 500 to the diluted RNA; followed by incubation at 45°C for 2 min. After incubating the 501 samples for at least 1 min on ice, 5 μl of RT master mix (containing 4 μl Reverse 502 Transcription Mix and 1 μl Reverse Transcription enzyme per sample) were added. 503 The resulting mixture was incubated for 3 min at 25°C, followed by incubation at 45°C 504 for 10 min and an inactivation step at 85°C for 5 min. The cDNA was either directly 505 used for the subsequent experiments or stored at -20°C. 506 qRT-PCRs were performed using the QuantiNova SYBR Green PCR Kit (QIAGEN, 507 Venlo, Netherlands). 1 μl cDNA was added to 19 μl master mix (containing 10 μl SYBR 508 Green, 1.5 μl Forward Primer (10 μM), 1.5 μl Reverse Primer (10 μM) and 6 μL RNase 509 free ddH2O per sample; for primer sequences see table 1), and the real time PCR 510 reaction was started using the following cycle conditions: 95l°C for 2 min, followed by 511 40 cycles of 95°C for 5 sec and 60°C for 10 sec. The qPCR cycle was ended by a stepwise 512 temperature-increase from 60°C to 95°C (1°C every 5 sec). Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19 The induction and 553 consequences of Influenza A virus-induced cell death SARS-CoV-2 (COVID-19) by the 555 numbers COVID-19 update: Covid-19-associated coagulopathy Steinmetzer, and 560 E. Böttcher-Friebertshäuser. 2020. TMPRSS2 and furin are both essential for 561 proteolytic activation of SARS-CoV-2 in human airway cells Type III interferons disrupt the 564 lung epithelial barrier upon viral recognition Pulmonary post-mortem findings in a series of COVID-19 cases from northern 568 Italy: a two-centre descriptive study The SARS-Coronavirus Membrane 570 protein induces apoptosis through modulating the Akt survival pathway Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage 574 Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice The cytokine storm in 577 COVID-19: An overview of the involvement of the chemokine/chemokine-receptor 578 system SARS-CoV-2 infection: The role of cytokines in COVID-19 disease Co-infection with Staphylococcus aureus after primary 585 influenza virus infection leads to damage of the endothelium in a human alveolus-on-586 a-chip model Early postmortem mapping of SARS-CoV-2 590 RNA in patients with COVID-19 and correlation to tissue damage Coronavirus infection, ER stress, apoptosis and innate 593 immunity Cytokine storm syndrome in coronavirus 595 disease 2019: A narrative review Pulmonary fibrosis and COVID-19: the 597 potential role for antifibrotic therapy Study 601 Group of the International Committee on Taxonomy of. 2020. The species Severe 602 acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it 603 SARS-CoV-2 Overcoming Barriers: The Endothelium As a Linchpin Coronavirus Disease High risk of thrombosis in patients with severe SARS-CoV-2 infection: a 612 multicenter prospective cohort study SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is 616 Blocked by a Clinically Proven Protease Inhibitor The cytokine storm and COVID-19 Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-621 19)? Host Immune Response and 623 Immunobiology of Human SARS-CoV-2 Infection A three-dimensional 628 immunocompetent intestine-on-chip model as in vitro platform for functional and 629 microbial interaction studies 2020. 632 SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation 633 and cytopathology Lung under attack by 635 COVID-19-induced cytokine storm: pathogenic mechanisms and therapeutic 636 implications The vascular endothelium: the cornerstone 638 of organ dysfunction in severe SARS-CoV-2 infection A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist 641 genomic epidemiology The ORF3a protein of SARS-CoV-2 induces apoptosis in cells. Cellular & 644 Molecular Immunology A microfluidically perfused three dimensional human 648 liver model Cell entry mechanisms 650 of SARS-CoV-2 The intracellular sites of early replication and budding of SARS-653 coronavirus On the origin and continuing evolution of SARS-CoV-2 Interferon and cytokine responses to SARS-coronavirus 658 infection Selective upregulation of TNFalpha 661 expression in classically-activated human monocyte-derived macrophages (M1) 662 through pharmacological interference with V-ATPase 667 Structural basis for translational shutdown and immune evasion by the Nsp1 protein 668 of SARS-CoV-2 Endothelial cell infection 671 and endotheliitis in COVID-19 Autopsy Findings and Venous 677 Thromboembolism in Patients With COVID-19 Antibody-dependent infection of human macrophages by 680 severe acute respiratory syndrome coronavirus ERGIC); (lower right panel, scale bar: 200 nm) viral release. (B) SARS-CoV-2 was 709 visualized by detection of the spike protein via a spike-specific antibody and an Alexa 710 Fluor™ 488-conjugated goat anti-mouse IgG (green). The nuclei were stained with 711 Immunofluorescence (IF) microscopy was acquired by use of the 712 Total cell lysates were 713 harvested at the times indicated and expression of the spike protein was analyzed by 714 western-blot assay. ERK2 served as loading control. (D) Progeny virus particles were 715 measured in the supernatant by standard plaque assay at the indicated times post 716 infection. Shown are means (±SD) of plaque forming units (PFU) ml -1 of three 717 independent experiments including two biological samples. Statistical significance 718 was analyzed by unpaired SARS-CoV-2 infection results in induction of antiviral and 721 proinflammatory mRNA synthesis Calu-3 cells were left uninfected (mock) or were infected with a SARS-CoV-2 patient 723 isolate (5159, 5587, 5588) (MOI=1) TNF, cIAP2, TRAIL, and RIPK1 mRNA 725 were measured of three patient isolate (5159, 5587, 5588) and two technical samples in 726 3 independent experiments. Means ± SD of three independent experiments are shown Levels of mock-treated samples were arbitrarily set as 1. After normalization, two-728 tailed unpaired t-tests were performed for comparison of mock-treated and SARS CoV-2-infected and samples (A) The E-cadherin of 737 the epithelial layer and the (B) VE-cadherin of the endothelial layer were visualized by 738 an anti-E-Cadherin-specific antibody or an anti-VE-Cadherin antiserum, respectively, 739 and a Cy5 goat anti-rabbit IgG (red). (A, B) The SARS-CoV-2 was visualized by 740 detection of the spike protein via a spike-specific antibody and an Alexa Fluor™ 488-741 conjugated goat anti-mouse IgG (green). The nuclei were stained with SARS-CoV-2 induced IFNβ, IFNλ1 and IFNλ2,3 release (pg/ml) was measured ± SD of three independent experiments each infected with another patient isolate 746 (5159, 5587, 5588) are shown. Levels of mock-treated samples were arbitrarily set as 1 After normalization, two-tailed unpaired t-tests were performed for comparison of 748 mock-treated and SARS-CoV-2-infected and samples 753 infected with the SARS-CoV-2 patient isolate (5159) (MOI=1) for 28h. An overview 754 (upper panel) of the (A) epithelial layer and (B) endothelial layer are depicted. Dead 755 cells (middle panel) are focused. The surface of dead cells (lower panel) shows 756 particles (arrows) attached to the plasma membranes of the epithelial cells only FITC-dextran was measured via the 762 fluorescence intensity (exc. 488nm; em. 518 nm) and depicted as the permeability 763 coefficient (Papp), calculated according to Papp (cm s −1 ) = (dQ/dt) (1/ACo). Results show 764 significant higher barrier permeability after SARS-CoV-2 infection. (D) Supernatants 765 of the epithelial-and endothelial side of SARS-CoV-2 infected human alveolus-on-a-766 chip models were used to perform LDH-assays indicating cell membrane rupture at 767 28h and Shown are means (±SD) of (C) three independent experiments each infected with 770 another patient isolate (5159, 5587, 5588), (D) LDH release, and (E) plaque forming 771 units (PFU/ml). Statistical significance was analyzed by unpaired, two-tailed t-test Calu-3, and HUVECs were infected with a SARS-CoV-2 patient isolate 776 (5159, 5587, 5588) (MOI=1). RNA-lysates were performed 24h p.i. and copies of viral 777 RNA (E-gene) were determined by r-biopharm qRT-PCR. Means ± SD of three 778 independent experiments are shown HUVECs were infected with a SARS-CoV-2 patient isolate (5159) (MOI=1) for 4h SARS-CoV-2 was visualized by detection of the spike protein via a spike-781 specific antibody and an Alexa Fluor™ 488-conjugated goat anti-mouse IgG (green) Immunofluorescence (IF) 783 microscopy was acquired by use of the Axio Observer.Z1 (Zeiss) with a Infection with SARS-CoV-2 results in the disruption of the epithelial-787 and endothelial barrier The epithelial side of the alveolus-on-a-chip model was left uninfected (mock) or 789 infected with three different SARS-CoV-2 patient isolates The E-cadherin of the 791 epithelial layer and the (B) VE-cadherin of the endothelial layer were visualized by an 792 anti-E-Cadherin-specific antibody or an anti-VE-Cadherin antiserum, respectively, 793 and a Cy5 goat anti-rabbit IgG (red). (A, B) The SARS-CoV-2 was visualized by 794 detection of the spike protein via a spike-specific antibody and an Alexa Fluor™ 488-795 conjugated goat anti-mouse IgG (green)